Zimmer Biomet Holdings (ZBH) Profit After Tax (2009 - 2026)
Zimmer Biomet Holdings (ZBH) recorded quarterly Profit After Tax of $238.1 million in Q1 2026, up 70.93% quarter-over-quarter from $139.3 million in Q4 2025, and up 30.82% on a YoY basis from $182.0 million in Q1 2025.
Zimmer Biomet Holdings (ZBH) Profit After Tax (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Profit After Tax history runs 18 years deep, the most recent figure standing at $238.1 million for Q1 2026.
- In Q1 2026, Profit After Tax rose 30.82% year-over-year to $238.1 million; the TTM figure through Mar 2026 stood at $761.7 million (down 16.74% YoY), while the FY2025 annual figure was $705.1 million, down 22.11% from the prior year.
- Profit After Tax was $238.1 million for Q1 2026 at Zimmer Biomet Holdings, up from $139.3 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $420.3 million in Q4 2023 to a low of -$130.5 million in Q4 2022.
- Historically, Profit After Tax has averaged $182.7 million across 5 years, with a median of $194.0 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Profit After Tax slumped 221.43% in 2022, then soared 1537.32% in 2023.
- A 5-year view of Profit After Tax shows it stood at -$130.5 million in 2022, then surged by 422.07% to $420.3 million in 2023, then tumbled by 42.68% to $240.9 million in 2024, then slumped by 42.18% to $139.3 million in 2025, then soared by 70.93% to $238.1 million in 2026.
- The last three Profit After Tax figures came in at $238.1 million (Q1 2026), $139.3 million (Q4 2025), and $230.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.14 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 170.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 238.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 238.10 Mn |
| Dec 31, 2025 | 139.30 Mn |
| Sep 30, 2025 | 230.90 Mn |
| Jun 30, 2025 | 153.40 Mn |
| Mar 31, 2025 | 182.00 Mn |
| Dec 31, 2024 | 240.90 Mn |
| Sep 30, 2024 | 249.10 Mn |
| Jun 30, 2024 | 242.80 Mn |
| Mar 31, 2024 | 172.80 Mn |
| Dec 31, 2023 | 420.30 Mn |
| Sep 30, 2023 | 162.70 Mn |
| Jun 30, 2023 | 209.90 Mn |
| Mar 31, 2023 | 232.50 Mn |
| Dec 31, 2022 | -130.50 Mn |
| Sep 30, 2022 | 194.00 Mn |
| Jun 30, 2022 | 154.00 Mn |
| Mar 31, 2022 | 14.20 Mn |
| Dec 31, 2021 | -40.60 Mn |
| Sep 30, 2021 | 145.60 Mn |
| Jun 30, 2021 | 141.90 Mn |